Raccoon canine distemper virus attenuated vaccine strain and its application in preparing live raccoon distemper vaccine
A technology of attenuated vaccine and raccoon dog distemper, which is applied in the direction of virus, antiviral agent, virus/phage, etc., can solve the problems of lack of special treatment methods and inability to obtain better immune protection effect, and achieve good immunogenicity, drop degree of stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0011] Embodiment 1 Domestication and Identification of Canine Distemper Virus Vaccine Strain CDV-O2
[0012] 1. Domestication of canine distemper virus vaccine strain CDV-O2
[0013] (1) Inoculate the preserved canine distemper virus vaccine strain CDV-O2 on African green monkey kidney cells (Vero) by adsorption and inoculation to carry out virus amplification and culture, observe the cell virus situation every day, and wait for the cytopathic changes to reach 80 % or so, the virus liquid was harvested by the method of repeated freezing and thawing, and the virus content (TCID 50 ≥10 5.0 / ml), sterility test. Aliquot the tested virus liquid and store it at -20°C.
[0014] (2) The amplified CDV-O2 virus liquid stock solution was inoculated into the hindlimb muscles of 3 antibody-negative healthy raccoon dogs, 5ml each, inoculated at three points, kept in isolation, and observed the physiological indicators of the inoculated raccoon dogs every day. On the 3rd and 5th day af...
Embodiment 2
[0021] Preparation of embodiment 2 raccoon dog distemper live vaccine (CDV-OR12 strain)
[0022] 1. Preparation of Canine Distemper Virus Seedling Solution
[0023] Take the preserved canine distemper virus attenuated vaccine strain CDV-OR12 and inoculate it on Vero cells by adsorption and inoculation for virus amplification and culture. Observe the cell virus situation every day. Methods The virus liquid was harvested and tested for virus content and purity. The content of raccoon canine distemper virus attenuated vaccine strain in the obtained virus liquid was TCID 50 ≥10 4.5 / ml. According to the measured virus content data, after appropriate dilution of the tested virus liquid with serum-free MEM, quantitatively dispense into 90ml vaccine bottles and store at -20°C.
[0024] 2. Determination of canine distemper virus content in finished vaccine products
[0025] Vaccine finished product is tested for virus content, canine distemper virus content TCID 50 for 10 4.5 -1...
Embodiment 3
[0026] Safety test of embodiment 3 raccoon dog distemper live vaccine (CDV-OR12 strain)
[0027] Get the qualified raccoon dog distemper live vaccine (prepared in embodiment 2), hindlimb muscle inoculation antibody negative raccoon dog, establish single dose (vaccinate 1 part, canine distemper virus content TCID 50 =10 4.5 / head), single-dose repeated and super-dose (10 times) immunization groups, and non-vaccinated raccoon dogs were set as negative controls. After vaccination, the body temperature, appetite, mental state, feces and other physiological indicators of raccoon dogs were observed for 14 consecutive days, and the lesions of the main organs of vaccinated raccoon dogs were observed by autopsy. The test results showed that after the single-dose, repeated single-dose and over-dose inoculation, all the physiological indexes of the raccoon dog were normal and did not show any clinical symptoms. Safe for raccoons.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More